Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Uncovering the pathogenic variants of genes attributed to rare X-linked human diseases
FY 2023-24
Summary
In the field of genetics and health care, it is crucial to be able to determine the underlying cause of genetic diseases when presented in humans. It is however challenging to determine specific mutations that attribute to rare diseases, as most genetic mutations are so rare that they have never previously been associated with disease. These novel mutations are known as variants of uncertain significance (VUS). In this research, I will use a budding yeast model system to obtain all possible mutations along genes involved in rare X-linked diseases in order to understand the consequences of these novel mutations, which is incredibly useful in classifying current VUS. Males only have one X-chromosome, so one inherited diseased X-linked gene will cause disease manifestation. Females with one inherited mutation will be carriers of the disease but have the potential to express disease symptoms due to random inactivation of genes on one of their two X-chromosomes. Some X-linked genes to be studied include ATP7a, responsible for Menkes Disease and Occipital Horn Syndrome, and NAA10, responsible for Ogden Syndrome. To test the suitability of a yeast disease model, I have already confirmed and recapitulated functionality of the human ATP7a gene in this model and will now confirm functionality of other human X-linked genes. Next, I will use deep mutational scanning, an approach used to identify all possible mutations on genes associated with rare diseases, where each mutation will be correlated with a unique barcode. By growing all mutants in a bulk fitness assay and by tracking the barcode frequency over time, I can determine the growth rate of every mutant simultaneously, and thus obtain the mutations that will disrupt gene function and ultimately attribute to disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506141
Name
Kindree Kortni L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Uncovering the pathogenic variants of genes attributed to rare X-linked human diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Carriers Of Genetic Disease; Deep Mutational Scanning; Genetic Counselling; Missense Variants; Mutagenesis; Pathogenic Mutations; Variant Effect Mapping; Variants Of Uncertain Significance; X-Linked Rare Diseases; Yeast Barcoding
Abstract
In the field of genetics and health care, it is crucial to be able to determine the underlying cause of genetic diseases when presented in humans. It is however challenging to determine specific mutations that attribute to rare diseases, as most genetic mutations are so rare that they have never previously been associated with disease. These novel mutations are known as variants of uncertain significance (VUS). In this research, I will use a budding yeast model system to obtain all possible mutations along genes involved in rare X-linked diseases in order to understand the consequences of these novel mutations, which is incredibly useful in classifying current VUS. Males only have one X-chromosome, so one inherited diseased X-linked gene will cause disease manifestation. Females with one inherited mutation will be carriers of the disease but have the potential to express disease symptoms due to random inactivation of genes on one of their two X-chromosomes. Some X-linked genes to be studied include ATP7a, responsible for Menkes Disease and Occipital Horn Syndrome, and NAA10, responsible for Ogden Syndrome. To test the suitability of a yeast disease model, I have already confirmed and recapitulated functionality of the human ATP7a gene in this model and will now confirm functionality of other human X-linked genes. Next, I will use deep mutational scanning, an approach used to identify all possible mutations on genes associated with rare diseases, where each mutation will be correlated with a unique barcode. By growing all mutants in a bulk fitness assay and by tracking the barcode frequency over time, I can determine the growth rate of every mutant simultaneously, and thus obtain the mutations that will disrupt gene function and ultimately attribute to disease.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kindree, Kortni L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~